Latest KFF Health News Stories
Inside the FDA’s Vaccine Uproar
An internal email claiming covid vaccines killed children triggered a formal response from a dozen past FDA commissioners. The email, sent by the head of the Center for Biologics Evaluation and Research, outlines a framework that could have significant impact on the nation’s vaccine policies.
What the Health? From KFF Health News: Time’s Up for Expanded ACA Tax Credits
A last-minute push from Democrats and four moderate Republicans will force a House vote on renewing enhanced premium tax credits for Affordable Care Act plans, but not until January. That means millions will have to choose between paying dramatically more or dropping coverage next year. Meanwhile, the Centers for Disease Control and Prevention officially drops the federal recommendation for newborns to receive a hepatitis B shot. Tami Luhby of CNN, Alice Miranda Ollstein of Politico, and Lizzy Lawrence of Stat join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Tony Leys, who wrote the latest “Bill of the Month” feature, and the panel discusses the year’s biggest developments in health policy.
FDA cuestiona uso de antidepresivos en el embarazo, pero médicos dicen que son esenciales
A expertos médicos les preocupa que una mesa redonda convocada en julio por la Administración de Alimentos y Medicamentos pueda provocar más casos de depresión no tratada.
FDA Panelists Questioned Antidepressants in Pregnancy. But Doctors Call Them a Lifeline.
Participants in an FDA panel discussion warned the public about risks from using antidepressants in pregnancy. But mental health issues, including suicide and overdoses, are the leading cause of maternal death in the United States. Antidepressants are a safe, well-studied way to help prevent those deaths, medical experts say.
What the Health? From KFF Health News: Crunch Time for ACA Tax Credits
Dec. 15 is the deadline to sign up for Affordable Care Act plans that begin Jan. 1, and Congress remains at odds over letting expanded tax credits for the plans’ premiums expire and increasing the cost of insurance for millions of Americans. Meanwhile, HHS Secretary Robert F. Kennedy Jr. continues to remake vaccine policy to reflect ideology rather than science. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sheryl Gay Stolberg of The New York Times join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Georgetown professor Linda Blumberg about the GOP’s health plans.
What the Health? From KFF Health News: The GOP Still Can’t Agree on a Health Plan
Senate Democrats were promised a vote by mid-December on extending enhanced Affordable Care Act subsidies, but Republicans still can’t decide whether they want to put forward their own alternative or what that might include. Meanwhile, the CDC and FDA are roiled by debates over vaccines. Alice Miranda Ollstein of Politico, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews KFF Health News’ Aneri Pattani about her project tracking opioid settlement payments.
Under Kennedy, America’s Health Department Is in the Business of Promoting Kennedy
Under Secretary Robert F. Kennedy Jr., the Department of Health and Human Services increasingly uses its social media channels to promote Kennedy himself and his agenda. Interviews with over 20 former and current employees provide a look inside an agency where personality and politics steer communications with the public.
What the Health? From KFF Health News: Trump Almost Unveils a Health Plan
Just weeks before some tax credits for Affordable Care Act premiums expire, the Trump administration floated a plan to extend the enhanced aid — but it was met with immediate GOP pushback. Meanwhile, health secretary Robert F. Kennedy Jr. says he ordered the Centers for Disease Control and Prevention to revise its website to suggest childhood vaccines might be linked to autism. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Joanne Kenen and Joshua Sharfstein about their new book, “Information Sick: How Journalism’s Decline and Misinformation’s Rise Are Harming Our Health — And What We Can Do About It.”
The Covid Contrarian Clubhouse Makes Its Mark on Trump’s Washington
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
What the Health? From KFF Health News: The Government Is Open
The record-long federal shutdown is over after a small group of Democrats agreed to a deal with most Republicans that funds the government through January — but, notably, does not extend more generous Affordable Care Act tax credits. Plus, new details are emerging about how the Trump administration is using the Medicaid program to advance its policy goals. Anna Edney of Bloomberg News, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, KFF Health News’ Julie Rovner interviews KFF Health News’ Julie Appleby, who wrote the latest “Bill of the Month” feature.
Readers Take Congress to Task and Offer Their Own Health Policy Fixes
KFF Health News gives readers a chance to comment on a recent batch of stories.
Para quienes tienen en su agenda de otoño vacunarse contra enfermedades respiratorias —covid, gripe y, para algunas personas, virus respiratorio sincitial (VRS) — este año puede resultar sorprendentemente normal.
Despite the Hoopla, Vaccines Should Be in Reach This Cough-and-Cold Season
Recommendations surrounding covid vaccinations and other such shots have been confusing. Ultimately, though, little has changed. Here’s what you need to know.
What the Health? From KFF Health News: Starting To Feel the Shutdown’s Bite
The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
‘Historic’ White House Announcement on Autism and Tylenol Causes Confusion
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Off-Label Drug Helps One Boy With Autism Speak, Parents Say. But Experts Want More Data.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
Trump Claims ‘No Downside’ to Avoiding Tylenol During Pregnancy. He’s Wrong.
Doctors say acetaminophen, the main ingredient in Tylenol, is safe to take during pregnancy. Other over-the-counter pain relievers such as aspirin and ibuprofen aren’t recommended because they can harm fetal development. Untreated fever in pregnancy can pose maternal and fetal health risks.
Journalists Follow the Fallout of CDC Director’s Firing and Trump’s Health Policies
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
